NEDD4L inhibits the proliferation of prostate cancer cells by degrading plant homeodomain finger protein 8 (PHF8/KDM7B) through the ubiquitin–proteasome system (Feng et al., 2023). Here, NEDD4L is linked to prostate carcinoma.